Cargando…
Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer
Ubiquitin C-terminal hydrolases (UCHs), a subfamily of deubiquitinating enzymes (DUBs), have been found in a variety of tumor entities and play distinct roles in the pathogenesis and development of various cancers including head and neck cancer (HNC). HNC is a heterogeneous disease arising from the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878561/ https://www.ncbi.nlm.nih.gov/pubmed/33585209 http://dx.doi.org/10.3389/fonc.2020.592501 |
_version_ | 1783650361701040128 |
---|---|
author | Rong, Chao Zhou, Ran Wan, Shan Su, Dan Wang, Shou-Li Hess, Jochen |
author_facet | Rong, Chao Zhou, Ran Wan, Shan Su, Dan Wang, Shou-Li Hess, Jochen |
author_sort | Rong, Chao |
collection | PubMed |
description | Ubiquitin C-terminal hydrolases (UCHs), a subfamily of deubiquitinating enzymes (DUBs), have been found in a variety of tumor entities and play distinct roles in the pathogenesis and development of various cancers including head and neck cancer (HNC). HNC is a heterogeneous disease arising from the mucosal epithelia of the upper aerodigestive tract, including different anatomic sites, distinct histopathologic types, as well as human papillomavirus (HPV)-positive and negative subgroups. Despite advances in multi-disciplinary treatment for HNC, the long-term survival rate of patients with HNC remains low. Emerging evidence has revealed the members of UCHs are associated with the pathogenesis and clinical prognosis of HNC, which highlights the prognostic and therapeutic implications of UCHs for patients with HNC. In this review, we summarize the physiological and pathological functions of the UCHs family, which provides enlightenment of potential mechanisms of UCHs family in HNC pathogenesis and highlights the potential consideration of UCHs as attractive drug targets. |
format | Online Article Text |
id | pubmed-7878561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78785612021-02-13 Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer Rong, Chao Zhou, Ran Wan, Shan Su, Dan Wang, Shou-Li Hess, Jochen Front Oncol Oncology Ubiquitin C-terminal hydrolases (UCHs), a subfamily of deubiquitinating enzymes (DUBs), have been found in a variety of tumor entities and play distinct roles in the pathogenesis and development of various cancers including head and neck cancer (HNC). HNC is a heterogeneous disease arising from the mucosal epithelia of the upper aerodigestive tract, including different anatomic sites, distinct histopathologic types, as well as human papillomavirus (HPV)-positive and negative subgroups. Despite advances in multi-disciplinary treatment for HNC, the long-term survival rate of patients with HNC remains low. Emerging evidence has revealed the members of UCHs are associated with the pathogenesis and clinical prognosis of HNC, which highlights the prognostic and therapeutic implications of UCHs for patients with HNC. In this review, we summarize the physiological and pathological functions of the UCHs family, which provides enlightenment of potential mechanisms of UCHs family in HNC pathogenesis and highlights the potential consideration of UCHs as attractive drug targets. Frontiers Media S.A. 2021-01-29 /pmc/articles/PMC7878561/ /pubmed/33585209 http://dx.doi.org/10.3389/fonc.2020.592501 Text en Copyright © 2021 Rong, Zhou, Wan, Su, Wang and Hess http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Rong, Chao Zhou, Ran Wan, Shan Su, Dan Wang, Shou-Li Hess, Jochen Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer |
title | Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer |
title_full | Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer |
title_fullStr | Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer |
title_full_unstemmed | Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer |
title_short | Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer |
title_sort | ubiquitin carboxyl-terminal hydrolases and human malignancies: the novel prognostic and therapeutic implications for head and neck cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878561/ https://www.ncbi.nlm.nih.gov/pubmed/33585209 http://dx.doi.org/10.3389/fonc.2020.592501 |
work_keys_str_mv | AT rongchao ubiquitincarboxylterminalhydrolasesandhumanmalignanciesthenovelprognosticandtherapeuticimplicationsforheadandneckcancer AT zhouran ubiquitincarboxylterminalhydrolasesandhumanmalignanciesthenovelprognosticandtherapeuticimplicationsforheadandneckcancer AT wanshan ubiquitincarboxylterminalhydrolasesandhumanmalignanciesthenovelprognosticandtherapeuticimplicationsforheadandneckcancer AT sudan ubiquitincarboxylterminalhydrolasesandhumanmalignanciesthenovelprognosticandtherapeuticimplicationsforheadandneckcancer AT wangshouli ubiquitincarboxylterminalhydrolasesandhumanmalignanciesthenovelprognosticandtherapeuticimplicationsforheadandneckcancer AT hessjochen ubiquitincarboxylterminalhydrolasesandhumanmalignanciesthenovelprognosticandtherapeuticimplicationsforheadandneckcancer |